(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-04 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 705300
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Thu Apr 2024 | 90.68 | 93.21 | 93.31 | 90.63 | 0.993 times |
| 03 Wed Apr 2024 | 92.23 | 90.42 | 93.36 | 90.31 | 0.827 times |
| 02 Tue Apr 2024 | 91.56 | 94.18 | 94.49 | 90.50 | 0.801 times |
| 01 Mon Apr 2024 | 96.42 | 95.00 | 97.00 | 93.70 | 0.858 times |
| 28 Thu Mar 2024 | 94.86 | 95.00 | 95.98 | 93.50 | 0.935 times |
| 27 Wed Mar 2024 | 94.79 | 90.08 | 94.91 | 89.12 | 1.129 times |
| 26 Tue Mar 2024 | 89.67 | 89.53 | 92.55 | 88.26 | 0.772 times |
| 25 Mon Mar 2024 | 88.22 | 87.59 | 89.58 | 86.76 | 0.478 times |
| 22 Fri Mar 2024 | 87.04 | 89.91 | 91.06 | 87.03 | 1.005 times |
| 21 Thu Mar 2024 | 90.05 | 89.13 | 91.81 | 89.13 | 1.385 times |
My analysis of stock is bullish for shortterm, and stock might move up till 93.1 or till 96.2. Use a stoploss of 90.54 and if this stock hits its stoploss, then it can fall down till 87.94
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 68.28 |
| Downside Target | 72.24 |
| Downside Target | 75.20 |
| Downside Target | 84.81 |
| Downside Target | 88.55 |
| Upside Target | 94.00 |
| Upside Target | 95.98 |
| Upside Target | 96.30 |
| Upside Target | 97.00 |
| Upside Target | 98.06 |
| Upside Target | 101.00 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 88.33 |
| Downside Intraday Target | 85.97 |
| Upside Intraday Target | 95.02 |
| Upside Intraday Target | 99.35 |
| Upside Intraday Target | 92.66 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Thu Apr 2024 | 90.68 | 95.00 | 97.00 | 90.31 | 1.05 times |
| 28 Thu Mar 2024 | 94.86 | 87.59 | 95.98 | 86.76 | 0.422 times |
| 22 Fri Mar 2024 | 87.04 | 90.86 | 91.81 | 84.81 | 1.625 times |
| 15 Fri Mar 2024 | 90.50 | 92.12 | 92.82 | 86.36 | 0.82 times |
| 08 Fri Mar 2024 | 92.30 | 95.26 | 96.30 | 88.55 | 0.754 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Thu Apr 2024 | 90.68 | 95.00 | 97.00 | 90.31 | 0.151 times |
| 28 Thu Mar 2024 | 94.86 | 93.81 | 98.06 | 84.81 | 0.82 times |
| 29 Thu Feb 2024 | 93.52 | 79.33 | 101.00 | 72.24 | 1.428 times |
| 31 Wed Jan 2024 | 79.53 | 90.54 | 93.07 | 75.20 | 0.637 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 91.66 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 91.66 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.